Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
Dec. 15, 1998 - Jan. 15, 1999
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1999
Report date:
1999

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
no
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
Study is from 1998

Test material

Constituent 1
Chemical structure
Reference substance name:
2-Ethoxy-4-{3-[(S)-3-methy-1-(2-piperidin-1-yl-phenyl)-butylamino]-2-oxo-propyl}-benzoic acid ethyl ester
EC Number:
604-604-0
Cas Number:
147770-06-7
Molecular formula:
C29 H40 N2 O4
IUPAC Name:
2-Ethoxy-4-{3-[(S)-3-methy-1-(2-piperidin-1-yl-phenyl)-butylamino]-2-oxo-propyl}-benzoic acid ethyl ester

In vivo test system

Test animals

Species:
guinea pig
Strain:
Dunkin-Hartley
Sex:
female
Details on test animals and environmental conditions:
10/5 (test/control) Hsd Poe : DH - guinea pigs (Full-Barrier) , Sex: female,
nulliparous, nonpregnant, body weight at the commencement of the study
302 - 315 g, age approx. 4-5 weeks.
The animals were derived from a controlled full barrier maintained breeding
system (spf).
Source: Harlan Winkelmann GmbH, D-33178 Borchen.
According to Art. 9.2, No.7 of the German Act on Animal Welfare the animals
were bred for experimental purposes.

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal and epicutaneous
Vehicle:
cotton seed oil
Concentration / amount:
Day 0:
Injectionvolume: 0.1ml
Injection 1: Freund's Adjuvant complete, 1+1 (v/v) diluted with isotonie saline
Injection 2: Test item 20%
Injection 3: Test item at a concentration of 10% (V/V) in Freund's Adjuvant complete, 1+1 (v/v) diluted with isotonie saline.

Day 7:
A pateh was fully loaded with the test item, applied to the test area and held
in contaet by an occlusive dressing for 48 hours
Day(s)/duration:
Day 0: intradermal;
Day 7: topical application, duration 48 hours
Adequacy of induction:
highest technically applicable concentration used
Route:
intradermal and epicutaneous
Vehicle:
cotton seed oil
Concentration / amount:
Day 0:
Injectionvolume: 0.1 ml
Injection 1: Freund's Adjuvant complete, 1+1 (v/v) diluted with isotonie saline
Injection 2: Cottonseed Oil
Injection 3: Cottonseed Oil at a concentration of 50% (VN) in Freund's Adjuvant complete, 1+1 (v/v) diluted with isotonie saline.

Day 7:
A patch was fully loaded with Cottonseed Oil and applied to the test area
and held in contact by an occlusive dressing for 48 hours.
Day(s)/duration:
Day 0 intradermal
Day 7 : topical application duration 48 hours
Adequacy of induction:
other: control
Challenge
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
100% test substance (left), cotton seed oil (right)
Day(s)/duration:
Day 20/ 24 hours
Adequacy of challenge:
highest non-irritant concentration
No. of animals per dose:
10/5 (test/control)
Details on study design:
RANGE FINDING TESTS: 3 animals topical treated with test item, no signs of irration were recorded after a contact period of 24 h.

Challenge controls:
A patch loaded with the test item was applied to the left flank of the animals
and, a patch loaded with Cottonseed Oil to the right flank (intraspecifie control), respectively. The patches were held in contact by an occlusive dressing for 24 hours. At the end of the chaIIenge skin was cleaned with the aid of moistened gauze patches.
Positive control substance(s):
yes
Remarks:
Mercaptobenzothiazole.

Results and discussion

Positive control results:
conducted in April/May 1998, concentrations: 2% induction -1 phase, 25% induction-2 phase, 15% in challenge, use of substance as positive control, having mild to moderate sensitizer properties. The study was considered valid.

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
20% test item Intradermal
100 % test item Topical Application
100% test item Challenge
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
no indication of skin sensitisation
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
100% Cottonseed Oil Intradermal
100 % Cottonseed Oil Topical Application
100% test item Challenge
No. with + reactions:
0
Total no. in group:
5
Remarks on result:
no indication of skin sensitisation
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
20% test item Intradermal
100 % test item Topical Application
100% test item Challenge
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
no indication of skin sensitisation
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
100% Cottonseed Oil Intradermal
100 % Cottonseed Oil Topical Application
100% test item Challenge
No. with + reactions:
0
Total no. in group:
5
Remarks on result:
no indication of skin sensitisation

Applicant's summary and conclusion

Interpretation of results:
other: not classified acc. to CLP
Conclusions:
Considering the reported data of this sensitization test it can be stated that
the test item AGEE 623 AMIDESTER caused no reactions identified as sensitization.
According to EEC criteria for classification (93/21/EEC) no labelling is necessary
as the sensitization rate was below 30%.
Executive summary:

During the induction phase the guinea pigs (10 test group, 5 control group
all females, strain: Hsd Poc:DH) were intradermally injected with a 20%
suspension of AGEE 623 AMID ESTER and topically treated with 100 %
AGEE 623 AMIDESTER. After a latency of 14 days - to allow a potential
reaction of the immune system - the animals were challenged with the test
item on the flank. The grade of skin reactions was compared to control animals,
which were treated with the vehicle ( cotton seed oil) during the induction
phase and, during challenge phase with the test item, respectively.
The sensitization rate after application of AGEE 623 AMIDESTER was
0 %. Under the test conditions described below the test item showed no sensitizing
properties. No other signs of toxicity were observed. All animals
showed normal food intake and weight gain.